Name | Number of supported studies | Average coverage | |
---|---|---|---|
basal cell | 12 studies | 29% ± 10% | |
ciliated cell | 5 studies | 28% ± 14% | |
respiratory goblet cell | 5 studies | 30% ± 7% | |
epithelial cell | 3 studies | 38% ± 7% | |
secretory cell | 3 studies | 29% ± 10% | |
club cell | 3 studies | 16% ± 0% |
Name | Number of supported studies | Average coverage | |
---|---|---|---|
lung | 3 studies | 19% ± 5% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
esophagus | 49% | 6137.23 | 704 / 1445 | 43% | 75.18 | 78 / 183 |
tonsil | 0% | 0 | 0 / 0 | 84% | 82.84 | 38 / 45 |
lung | 46% | 71.71 | 265 / 578 | 30% | 65.40 | 350 / 1155 |
stomach | 74% | 386.58 | 267 / 359 | 1% | 0.16 | 3 / 286 |
liver | 54% | 10.26 | 121 / 226 | 0% | 0.02 | 1 / 406 |
skin | 53% | 17.06 | 952 / 1809 | 0% | 0 | 0 / 472 |
uterus | 19% | 9.99 | 32 / 170 | 31% | 42.65 | 142 / 459 |
adipose | 25% | 3.85 | 304 / 1204 | 0% | 0 | 0 / 0 |
bladder | 10% | 1.62 | 2 / 21 | 11% | 15.68 | 57 / 504 |
breast | 19% | 3.06 | 87 / 459 | 2% | 0.32 | 18 / 1118 |
prostate | 16% | 3.70 | 38 / 245 | 0% | 0 | 0 / 502 |
blood vessel | 11% | 1.69 | 144 / 1335 | 0% | 0 | 0 / 0 |
intestine | 8% | 1.25 | 76 / 966 | 2% | 1.45 | 12 / 527 |
adrenal gland | 9% | 1.23 | 24 / 258 | 0% | 0 | 0 / 230 |
ovary | 9% | 1.42 | 16 / 180 | 0% | 0 | 0 / 430 |
spleen | 8% | 1.49 | 20 / 241 | 0% | 0 | 0 / 0 |
thymus | 7% | 1.48 | 44 / 653 | 1% | 0.17 | 6 / 605 |
pancreas | 7% | 1.16 | 24 / 328 | 0% | 0 | 0 / 178 |
heart | 5% | 0.55 | 41 / 861 | 0% | 0 | 0 / 0 |
peripheral blood | 3% | 1.47 | 32 / 929 | 0% | 0 | 0 / 0 |
kidney | 3% | 0.56 | 3 / 89 | 0% | 0 | 0 / 901 |
muscle | 3% | 1.94 | 23 / 803 | 0% | 0 | 0 / 0 |
brain | 2% | 0.48 | 64 / 2642 | 0% | 0 | 0 / 705 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 80 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 29 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0001523 | Biological process | retinoid metabolic process |
GO_0010430 | Biological process | fatty acid omega-oxidation |
GO_0045471 | Biological process | response to ethanol |
GO_0042573 | Biological process | retinoic acid metabolic process |
GO_0042572 | Biological process | retinol metabolic process |
GO_0009617 | Biological process | response to bacterium |
GO_0005829 | Cellular component | cytosol |
GO_0005886 | Cellular component | plasma membrane |
GO_0048019 | Molecular function | receptor antagonist activity |
GO_0050153 | Molecular function | omega-hydroxydecanoate dehydrogenase activity |
GO_0004024 | Molecular function | alcohol dehydrogenase (NAD+) activity, zinc-dependent |
GO_0004022 | Molecular function | alcohol dehydrogenase (NAD+) activity |
GO_0004745 | Molecular function | all-trans-retinol dehydrogenase (NAD+) activity |
GO_0019841 | Molecular function | retinol binding |
GO_0004031 | Molecular function | aldehyde oxidase activity |
GO_0035276 | Molecular function | ethanol binding |
GO_0008270 | Molecular function | zinc ion binding |
Gene name | ADH7 |
Protein name | All-trans-retinol dehydrogenase [NAD(+)] ADH7 (EC 1.1.1.105) (Alcohol dehydrogenase class 4 mu/sigma chain) (EC 1.1.1.1) (Alcohol dehydrogenase class IV mu/sigma chain) (Gastric alcohol dehydrogenase) (Omega-hydroxydecanoate dehydrogenase ADH7) (EC 1.1.1.66) (Retinol dehydrogenase) Alcohol dehydrogenase 7 (class IV), mu or sigma polypeptide |
Synonyms | |
Description | FUNCTION: Catalyzes the NAD-dependent oxidation of all-trans-retinol, alcohol, and omega-hydroxy fatty acids and their derivatives . Oxidizes preferentially all trans-retinol, all-trans-4-hydroxyretinol, 9-cis-retinol, 2-hexenol, and long chain omega-hydroxy fatty acids such as juniperic acid . In vitro can also catalyzes the NADH-dependent reduction of all-trans-retinal and aldehydes and their derivatives . Reduces preferentially all trans-retinal, all-trans-4-oxoretinal and hexanal . Catalyzes in the oxidative direction with higher efficiency . Therefore may participate in retinoid metabolism, fatty acid omega-oxidation, and elimination of cytotoxic aldehydes produced by lipid peroxidation . . |
Accessions | A0A0C4DG85 E9PFG0 ENST00000482593.5 ENST00000437033.7 ENST00000209665.8 [P40394-1] C9JP14 P40394 ENST00000476959.5 [P40394-2] ENST00000474027.1 |